FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

15642211000001108: Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
55214601000001116 Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
55214701000001114 Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet Has VMP Bismuth subsalicylate 262.5mg chewable tablets sugar free true Inferred relationship Existential restriction modifier
Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet Has specific active ingredient Bismuth subsalicylate true Inferred relationship Existential restriction modifier
Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Pepto-Bismol 262.5mg chewable tablets (Procter & Gamble (Health & Beauty Care) Ltd) 24 tablet 4 x 6 tablets Is a True Bismuth subsalicylate 262.5mg chewable tablets sugar free 24 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start